Search
Search Results
##search.searchResults.foundPlural##
-
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1448PDF: 1227HTML: 166 -
The diagnostic pitfalls of mucormycosis
1058PDF: 776HTML: 305 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2286PDF: 922HTML: 379 -
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
3588PDF: 815HTML: 1134Cover Letter: 247 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2450PDF: 1905HTML: 1065 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3910PDF: 1180HTML: 2505Figure 1: 248 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
607PDF: 303HTML: 152 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1700PDF: 1190HTML: 277 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2465PDF: 799HTML: 2157Untitled: 280Untitled: 200Untitled: 231Untitled: 212Untitled: 226Untitled: 248Untitled: 235 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3258PDF: 954HTML: 6624Untitled: 291Untitled: 247Untitled: 265Untitled: 272 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3527PDF: 2095HTML: 7584 -
-
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2313PDF: 2026HTML: 536 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4676PDF: 1567HTML: 8551 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
2005PDF: 532HTML: 4052 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2997PDF: 1196HTML: 3086 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7182PDF: 3814HTML: 847 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1437PDF: 1035HTML: 517 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2576PDF: 1063HTML: 439Supplementary table 1: 263Some of the mutation detection samples: 277 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3869PDF: 1348HTML: 3957Untitled: 287Untitled: 319 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2082PDF: 1192HTML: 1939Lung computed tomography CT scan image: 242 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1328PDF: 678HTML: 324 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2192PDF: 1139HTML: 983Figure 1: 216Figure 2: 238







